The impact of needleless connector device design on central venous catheter occlusion in children: A prospective, controlled trial

Journal of Parenteral and Enteral Nutrition

Volumn 30, Issue 2, 2006, Pages 85-90

  Schilling, Susan ^a   Doellman, Darcy ^a   Hutchinson, Nancy ^a   Jacobs, Brian R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; SODIUM CHLORIDE;

ARTICLE; CATHETER OCCLUSION; CENTRAL VENOUS CATHETER; DEVICE; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RATE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; VALVE; CENTRAL VENOUS CATHETERIZATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EQUIPMENT; INSTRUMENTATION; STATISTICS;

CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; EQUIPMENT FAILURE; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 33745485096     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710603000285     Document Type: Article

References (27)

1. Stephens LC, Haire WD, Kotulak GD. Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN J Parenter Enteral Nutr. 1995;19:75-79.
2. Hoch JR. Management of the complications of long term venous access. Semin Vasc Surg. 1997;10:135-143.
3. Jacobs BR. Central venous catheter occlusion and thrombosis. Crit Care Clin. 2003;19:489-514.
4. Rumsey KA, Richardson DK. Management of infection and occlusion associated with vascular access devices. Semin Oncol Nurs. 1995;11:174-183.
5. Krzywda EA. Predisposing factors, prevention and management of central venous catheter occlusions. J Intraven Nurs. 1999;22(6 suppl):S11-S17.
6. Jacobs BR, Schilling S, Doellman D, Hutchinson N, Rickey M, Nelson S. Central venous catheter occlusion: a prospective, controlled trial examining the impact of a positive-pressure valve device. JPEN J Parenter Enteral Nutr. 2004;28:113-118.
7. Rummel MA, Donnelly PJ, Fortenbaugh C. Clinical evaluation of a positive pressure device to prevent central venous catheter occlusion: results of a pilot study. Clin J Oncol Nurs. 2001;5:261-265.
8. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections: the Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Pediatrics. 2002;110:e51.
9. Garner IS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control. 1988; 16:128-140.
10. Deitcher SR, Fesen MR, Kiproff PM, et al. Safety and efficiency of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombotic to open occluded lines trial. J Clin Oncol. 2002;20:317-324.
11. Racadio JM, Doellman DA, Johnson ND, Bean JA, Jacobs BA. Pediatric peripherally inserted central catheters: complication rates related to catheter tip location. Pediatrics. 2001;107:E28.
12. Fratino G, Molinari A, Mazzola C, et al. Prospective study of indwelling central venous catheter-related complications in children with Broviac or clampless valved catheters. J Pediatr Hematol Oncol. 2002;24:657-661.
13. Andris DA, Krzywda EA, Schulte W, Ausman R, Quebbeman EJ. Pinch off syndrome: a rare etiology for central venous catheter occlusions. JPEN J Parenter Enteral Nutr. 1994;18:531-533.
14. Cassidy FP, Zajko AB, Bron KM, Reilly JJ, Peitzman AB, Steed DL. Noninfectious complications of long term central venous catheters: radiology evaluation and management. Am J Radiol. 1987;149:671-675.
15. Knue M, Doellman D, Rabin K, Jacobs BR. The efficacy and safety of blood sampling through peripherally inserted central catheter devices in children. J Infus Nurs. 2005;28:30-35.
16. Shah PS, Ng E, Sinha AK. Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database Syst Rev. 2004;4CD002774.
17. Rabe C, Gramann T, Sons X, et al. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Med. 2002;28:1172-1176.
18. Meyer BA, Little CJ, Thorp JA, Cohen GR, Yeast JD. Heparin versus normal saline as a peripheral line flush in maintenance of intermittent intravenous lines in obstetric patients. Obstet Gyncol. 1995;85:433-436.
19. Terry J, Baranowski L, Lonsway RA, Hedrick C, eds. Intravenous Therapy: Clinical Principles and Practice. Philadelphia, PA: Saunders; 1995.
20. Shah P, Shah V. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev. 2001;CD002772.
21. Hadaway LC. Major thrombolytic and non-thrombolytic complications: loss of patency. J Intraven Nurs. 1998;21(5 suppl):S143-S160.
22. Hoshal VL, Ause RG, Hoskins PA. Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg. 1991;102:353-357.
23. Cheeseman D. Intravenous care: the benefits of closed-system connectors. B J Nurs. 2001;10:287-295.
24. Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS. A randomized, prospective clinical trial to assess the potential infection risk associated with the Posiflow needleless connector. J Hosp Infect. 2003;54:288-293.
25. Elliott TS, Curran A. Effects of heparin and chlorbutol on bacterial colonization of intravascular cannulae in an in vitro model. J Hosp Infect. 1989;14:193-200.
26. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled studies. Chest. 1998;113: 165-171.
27. Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr. 2001;139:593-596.